printemailclick to share buttonfacebooktwitterlinkedin
What’s New
 

New or updated within the last month


Title           DescriptionDocument Type
NIVL(MNT) Gastrointestinal - Colorectal
nivolumab

Notes: New ST-QBP regimen
Regimen Monograph
NIVL+IPIL Gastrointestinal - Colorectal
nivolumab-ipilimumab

Notes: New ST-QBP regimen
Regimen Monograph
MFOLFOX6 Gastrointestinal - Hepatobiliary / Liver / Bile Duct
Folinic Acid (Leucovorin)-Fluorouracil-Oxaliplatin

Notes: New ST-QBP regimen
Regimen Monograph
CISPDOCEFU Gastrointestinal - Anus
CISplatin-DOCEtaxel-Fluorouracil

Notes: New ST-QBP regimen
Regimen Monograph
DARA(MNT) Hematologic - Multiple Myeloma
Daratumumab Maintenance

Notes: New ST-QBP regimen
Regimen Monograph
BORTDEXADARA Hematologic - Multiple Myeloma
Bortezomib-Dexamethasone-Daratumumab

Notes: Updated with NDFP funding
Regimen Monograph
DARADEXALENA Hematologic - Multiple Myeloma
daratumumab-dexamethasone-lenalidomide

Notes: Updated with NDFP and EAP funding information
Regimen Monograph
daratumumab Other names: Darzalex®
Notes: Added NDFP funding information
Drug Monograph
FCM+R Hematologic - Leukemia - Chronic Lymphocytic (CLL)
Fludarabine-Cyclophosphamide-mitoXANTRONE-riTUXimab

Notes: Added rituximab (subcut) information
Regimen Monograph
FLUD(PO)+R Hematologic - Leukemia - Chronic Lymphocytic (CLL)
Fludarabine (oral)-riTUXimab

Notes: Added rituximab (subcut) information
Regimen Monograph
FLUD+R Hematologic - Leukemia - Chronic Lymphocytic (CLL)
Fludarabine-riTUXimab

Notes: Added rituximab (subcut) information
Regimen Monograph
FC(PO)+R Hematologic - Leukemia - Chronic Lymphocytic (CLL)
Fludarabine (oral)-Cyclophosphamide (oral)-Rituximab

Notes: Added rituximab (subcut) option
Regimen Monograph
FC+R Hematologic - Leukemia - Chronic Lymphocytic (CLL)
Fludarabine-Cyclophosphamide-Rituximab

Notes: Updated with ritux(subcut) option
Regimen Monograph
paclitaxel Other names: Taxol®
Notes: Updated hepatic dosing table
Drug Monograph
PACL Genitourinary - Bladder / Urothelial
PACLitaxel

Notes: Updated dose modifications, adverse effects, interactions, drug administration/precautions, monitoring sections
Regimen Monograph
PACL Gastrointestinal - Esophagus; Gastrointestinal - Gastric / Stomach
PACLitaxel

Notes: Updated dose modifications, adverse effects, interactions, drug administration/precautions, monitoring sections
Regimen Monograph
PACL Sarcoma - Kaposi's Sarcoma
PACLitaxel

Notes: edited hepatic dose modifications table
Regimen Monograph
PACL Gynecologic - Ovary
PACLitaxel

Notes: edited hepatic dose modifications table
Regimen Monograph
PACL(W) Lung - Non-Small Cell
PACLitaxel (weekly)

Notes: edited hepatic dose modifications table
Regimen Monograph
PACL Lung - Non-Small Cell
PACLitaxel

Notes: edited hepatic dose modifications table
Regimen Monograph
1-20 of 24  result(s) NEXT
Last modified: Thu, Jan 15, 2015
cancer care ontario | action cancer ontario   620 University Avenue Toronto Ontario, Canada M5G 2L7   Phone: 416.971.9800 Fax: 416.971.6888

Please help improve the quality of our website by answering 10 brief questions in our online survey. Would you like to participate?

YesNo